Nalbuphine versus Midazolam as an Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section

Overview of attention for article published in Journal of Pain Research, June 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 1 X users, with an upper bound of 4,623 followers.

New2Trip: Nalbuphine versus Midazolam as Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section https://t.co/15so4AbM3f

15 Sep 2020

Reply Repost Favourite

New2Trip: Nalbuphine versus Midazolam as Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section https://t.co/15so4AbM3f

01 Sep 2020

Reply Repost Favourite

New2Trip: Nalbuphine versus Midazolam as Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section https://t.co/15so4AbM3f

22 Aug 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Nalbuphine versus Midazolam as an Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section

Mentioned by

Citations

Readers on